3-(4-Amino-phenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester

ID: ALA302855

Chembl Id: CHEMBL302855

Cas Number: 134052-62-3

PubChem CID: 14760414

Max Phase: Preclinical

Molecular Formula: C16H22N2O2

Molecular Weight: 274.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)C1C(c2ccc(N)cc2)CC2CCC1N2C

Standard InChI:  InChI=1S/C16H22N2O2/c1-18-12-7-8-14(18)15(16(19)20-2)13(9-12)10-3-5-11(17)6-4-10/h3-6,12-15H,7-9,17H2,1-2H3

Standard InChI Key:  NFYQZRCMOMKICY-UHFFFAOYSA-N

Associated Targets(non-human)

Slc6a3 Dopamine transporter (6071 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Dopamine transporter (17 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bos taurus (956 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gabrp GABA-A receptor; anion channel (5731 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 274.36Molecular Weight (Monoisotopic): 274.1681AlogP: 2.01#Rotatable Bonds: 2
Polar Surface Area: 55.56Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.36CX LogP: 1.68CX LogD: -0.27
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.66Np Likeness Score: 0.69

References

1. Kline RH, Wright J, Fox KM, Eldefrawi ME..  (1990)  Synthesis of 3-arylecgonine analogues as inhibitors of cocaine binding and dopamine uptake.,  33  (7): [PMID:2362282] [10.1021/jm00169a036]
2. Good AC, Peterson SJ, Richards WG..  (1993)  QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.,  36  (20): [PMID:8411009] [10.1021/jm00072a012]
3. Lieske SF, Yang B, Eldefrawi ME, MacKerell AD, Wright J..  (1998)  (-)-3 beta-Substituted ecgonine methyl esters as inhibitors for cocaine binding and dopamine uptake.,  41  (6): [PMID:9526561] [10.1021/jm970025h]

Source